Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MBP/MBL Antikörper

Dieses Anti-MBP/MBL-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von MBP/MBL in WB, IHC (fro), FACS, BR und IA. Geeignet für Human. Dieses Primary Antibody wurde in 5+ Publikationen zitiert.
Produktnummer ABIN2191923

Kurzübersicht für MBP/MBL Antikörper (ABIN2191923)

Target

Alle MBP/MBL Antikörper anzeigen
MBP/MBL (Mannan Binding Protein/Mannan Binding Lectin (MBP/MBL))

Reaktivität

  • 8
  • 4
  • 4
  • 1
  • 1
  • 1
Human

Wirt

  • 10
  • 3
  • 1
Maus

Klonalität

  • 10
  • 4
Monoklonal

Konjugat

  • 14
Dieser MBP/MBL Antikörper ist unkonjugiert

Applikation

  • 12
  • 10
  • 9
  • 8
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro)), Flow Cytometry (FACS), Blocking Reagent (BR), Immunoassay (IA)

Klon

3E7
  • Aufreinigung

    Protein G

    Sterilität

    0.2 μm filtered

    Endotoxin-Niveau

    <24 EU/mg
  • Applikationshinweise

    For Western blotting, flow cytometry and immunohistology dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50. For neutralization of biological activity dilutions have to be made according to the amounts MBL to be inactivated.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Buffer

    PBS+0.1%BSA

    Lagerung

    4 °C

    Informationen zur Lagerung

    Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.

    Haltbarkeit

    12 months
  • de Vries, Walter, Peutz-Kootstra, Wolfs, van Heurn, Buurman: "The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury." in: The American journal of pathology, Vol. 165, Issue 5, pp. 1677-88, (2004) (PubMed).

    Nauta, Castellano, Xu, Woltman, Borrias, Daha, van Kooten, Roos: "Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 173, Issue 5, pp. 3044-50, (2004) (PubMed).

    Nauta, Raaschou-Jensen, Roos, Daha, Madsen, Borrias-Essers, Ryder, Koch, Garred: "Mannose-binding lectin engagement with late apoptotic and necrotic cells." in: European journal of immunology, Vol. 33, Issue 10, pp. 2853-63, (2003) (PubMed).

    Hisano, Matsushita, Fujita, Endo, Takebayashi: "Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis." in: American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 38, Issue 5, pp. 1082-8, (2001) (PubMed).

    Matsushita, Takahashi, Hatsuse, Kawakami, Fujita: "Human mannose-binding protein is identical to a component of Ra-reactive factor." in: Biochemical and biophysical research communications, Vol. 183, Issue 2, pp. 645-51, (1992) (PubMed).

  • Target

    MBP/MBL (Mannan Binding Protein/Mannan Binding Lectin (MBP/MBL))

    Andere Bezeichnung

    Mbl

    Hintergrund

    Mannose Binding Lectin (MBL) also called mannose- or mannan-binding protein (MBP) is a member of the group of collectins. MBL is an oligomeric lectin that recognizes carbohydrates as mannose and N- acetylglucosamine on pathogens. MBL contains a cysteine rich, a collagen like and a carbohydrate recognition domain. It forms a complex with C1r/C1s like serine proteases designated MASPs that proteolytically cleave C4, C2 and C3. MBL is able to activate the complement pathway independent of the classical and alternative complement activation pathways. The MBL-MASP pathway (better known as the lectin pathway) is antibody and C1q-independent. MBL exhibits complement-dependent antibacterial activity and acts directly as an opsonic and therefore plays an important role in innate immunity. MBL is synthesized by hepatocytes and has been isolated from the liver or serum of various vertebrate species.
Sie sind hier:
Chat with us!